Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-107712
Filing Date
2024-10-10
Accepted
2024-10-10 16:18:37
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm2424909-4_424b5.htm 424B5 328283
2 GRAPHIC lg_proqr-4c.jpg GRAPHIC 16893
3 GRAPHIC fc_programs-4c.jpg GRAPHIC 87502
4 GRAPHIC fc_natural-4clr.jpg GRAPHIC 67652
5 GRAPHIC lg_cantor-4c.jpg GRAPHIC 9370
  Complete submission text file 0001104659-24-107712.txt   579086
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282419 | Film No.: 241365443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)